0 likes | 0 Views
The growing role of AI and automation in hashtag#biosimilar production marks a major step toward Bioprocessing 4.0, enhancing efficiency across manufacturing and research. These technologies not only streamline operations but also support critical tasks like bioequivalence studies, detecting molecular variances, and predicting stability.<br><br>As biosimilars continue to reshape healthcare economics, adopting advanced tech enables greater scalability, sustainability, and process optimizationu2014ultimately reducing costs and improving access to affordable biopharmaceutical alternatives.
E N D